VolitionRx Limited Schedules Second Quarter 2024 Earnings Conference Call and Business Update
VolitionRx (NYSE AMERICAN: VNRX) has announced a conference call scheduled for Thursday, August 15, 2024, at 8:30 a.m. U.S. Eastern Time to discuss its financial and operating results for the second quarter of 2024 and provide a business update. The call will be hosted by key executives including Louise Batchelor, Cameron Reynolds, Terig Hughes, and Dr. Andrew Retter. Participants can join via phone or listen to a live audio webcast on Volition's investor relations website. A replay of the call will be available until August 29, 2024. This event provides an opportunity for investors and analysts to gain insights into Volition's recent performance and future outlook.
VolitionRx (NYSE AMERICAN: VNRX) ha annunciato una conference call programmata per giovedì 15 agosto 2024, alle 8:30 a.m. ora orientale degli Stati Uniti per discutere i suoi risultati finanziari e operativi per il secondo trimestre del 2024 e fornire un aggiornamento sull'azienda. La call sarà ospitata da dirigenti chiave, tra cui Louise Batchelor, Cameron Reynolds, Terig Hughes e Dr. Andrew Retter. I partecipanti potranno unirsi per telefono o ascoltare una diretta audio sul sito web delle relazioni con gli investitori di Volition. Una registrazione della call sarà disponibile fino al 29 agosto 2024. Questo evento offre l'opportunità agli investitori e agli analisti di acquisire informazioni sulla recente performance di Volition e sulle prospettive future.
VolitionRx (NYSE AMERICAN: VNRX) ha anunciado una conferencia telefónica programada para el jueves 15 de agosto de 2024, a las 8:30 a.m. hora del este de EE. UU. para discutir sus resultados financieros y operativos del segundo trimestre de 2024 y proporcionar una actualización de la empresa. La llamada será dirigida por ejecutivos clave, incluidos Louise Batchelor, Cameron Reynolds, Terig Hughes y el Dr. Andrew Retter. Los participantes pueden unirse por teléfono o escuchar una transmisión en vivo en el sitio web de relaciones con los inversores de Volition. Una repetición de la llamada estará disponible hasta el 29 de agosto de 2024. Este evento brinda la oportunidad a inversores y analistas de obtener información sobre el desempeño reciente de Volition y sus perspectivas futuras.
VolitionRx (NYSE AMERICAN: VNRX)는 2024년 8월 15일 목요일 오전 8시 30분(미국 동부 시간)에 2024년 2분기 재무 및 운영 결과에 대해 논의하고 사업 업데이트를 제공하는 컨퍼런스 콜을 공지했습니다. 이 콜은 Louise Batchelor, Cameron Reynolds, Terig Hughes, 그리고 Dr. Andrew Retter 등 주요 경영진이 주관할 것입니다. 참여자들은 전화로 접속하거나 Volition의 투자자 관계 웹사이트에서 실시간 오디오 웹캐스트를 청취할 수 있습니다. 이 콜의 재방송은 2024년 8월 29일까지 제공될 예정입니다. 이 이벤트는 투자자와 분석가에게 Volition의 최근 성과와 향후 전망에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
VolitionRx (NYSE AMERICAN: VNRX) a annoncé une conférence téléphonique prévue pour jeudi 15 août 2024, à 8h30 (heure de l'Est des États-Unis) afin de discuter de ses résultats financiers et opérationnels du deuxième trimestre 2024 et de fournir une mise à jour de l'entreprise. L'appel sera animé par des cadres clés tels que Louise Batchelor, Cameron Reynolds, Terig Hughes et Dr. Andrew Retter. Les participants peuvent se joindre par téléphone ou écouter une diffusion audio en direct sur le site web des relations investisseurs de Volition. Un enregistrement de l'appel sera disponible jusqu'au 29 août 2024. Cet événement offre aux investisseurs et analystes la possibilité d'obtenir des informations sur la récente performance de Volition et ses perspectives d'avenir.
VolitionRx (NYSE AMERICAN: VNRX) hat eine Telefonkonferenz für Donnerstag, den 15. August 2024, um 8:30 Uhr (Eastern Time, USA) angekündigt, um die Finanz- und Betriebsergebnisse für das zweite Quartal 2024 zu erörtern und ein Unternehmensupdate bereitzustellen. Die Konferenz wird von Schlüsselmanagern wie Louise Batchelor, Cameron Reynolds, Terig Hughes und Dr. Andrew Retter geleitet. Teilnehmer können telefonisch teilnehmen oder einen Live-Audio-Stream auf der Investor-Relations-Website von Volition anhören. Eine Wiederholung der Telefonkonferenz ist bis zum 29. August 2024 verfügbar. Diese Veranstaltung bietet eine Gelegenheit für Investoren und Analysten, Einblicke in die jüngsten Leistungen und zukünftige Perspektiven von Volition zu erhalten.
- None.
- None.
Conference call to take place on Thursday August 15 at 8:30 a.m.
Event: VolitionRx Limited Second Quarter 2024 Earnings and Business Update Conference Call
Date: Thursday, August 15, 2024
Time: 8:30 a.m.
Toll/International: 1-201-493-6779
Conference ID: 13747711
Louise Batchelor, Group Chief Marketing & Communications Officer will host the call along with Cameron Reynolds, President and Group Chief Executive Officer of Volition, Terig Hughes, Group Chief Financial Officer and Dr. Andrew Retter, Chief Medical Officer. The call will provide an update on important events that have taken place in the second quarter of 2024 and upcoming milestones.
A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website at https://ir.volition.com. In addition, a telephone replay of the call will be available until August 29, 2024. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the
About Volition
Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.
Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help diagnose and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early diagnosis and monitoring have the potential to not only prolong the life of patients, but also improve their quality of life.
Volition's research and development activities are centered in
The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document. Such website address is included in this document as an inactive textual reference only.
Media Enquiries:
Louise Batchelor/Debra Daglish, Volition, mediarelations@volition.com +44 (0)7557 774620
View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-second-quarter-2024-earnings-conference-call-and-business-update-302215437.html
SOURCE VolitionRx Limited
FAQ
When is VolitionRx (VNRX) hosting its Q2 2024 earnings call?
How can investors join VolitionRx's (VNRX) Q2 2024 earnings conference call?
Until what date will the replay of VolitionRx's (VNRX) Q2 2024 earnings call be available?
Who will be hosting VolitionRx's (VNRX) Q2 2024 earnings conference call?
